Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
about
Comparative Anatomy of Phagocytic and Immunological SynapsesT Lymphocyte Migration: An Action Movie Starring the Actin and Associated Actors.The cytoskeleton in cell-autonomous immunity: structural determinants of host defenceDedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development.Genome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome RegionsDifferential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells.T Cell Motility as Modulator of Interactions with Dendritic CellsRecurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal associationLow Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency.DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection.DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventions.Identification of Sequence Variants within Experimentally Validated Protein Interaction Sites Provides New Insights into Molecular Mechanisms of Disease Development.Genomics of Immune Diseases and New Therapies.From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?Primary Immunodeficiency Diseases in Highly Consanguineous Populations from Middle East and North Africa: Epidemiology, Diagnosis, and Care.Antigen Availability and DOCK2-Driven Motility Govern CD4+ T Cell Interactions with Dendritic Cells In Vivo.Germline mutations predisposing to diffuse large B-cell lymphoma.Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2.Advances in clinical immunology in 2015.DOCK8 deficiency: Insights into pathophysiology, clinical features and management.Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation.Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation.Severe combined immunodeficiencies and related disorders.DOCK2: A novel FLT3/ITD leukemia drug target.A functional genomics predictive network model identifies regulators of inflammatory bowel disease.DOCK2 Deficiency in a Patient with Hyper IgM Phenotype.The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production.SOS1, ARHGEF1, and DOCK2 rho-GEFs Mediate JAK-Dependent LFA-1 Activation by Chemokines.DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.
P2860
Q26767452-0F7B09E2-9036-4C52-83D0-0C50014B1F48Q26774663-E6F5100D-A29A-44BE-B71F-7AB6321965ABQ26796274-DC8F27E8-1958-4BD3-9DB2-EC1B1FB6BDC4Q30008878-77C23E9B-311D-4371-96F5-4785CB9C5F0AQ30274962-18A46FEA-301C-4078-97AF-D733B83D93A8Q32186337-41E41D33-1386-4CC9-BD5B-CA73717D2547Q36239225-9E90D77D-2C70-4BC2-8229-392D636F524AQ36665082-D42B1419-F422-4BD3-810B-5BDCC6EE7C6CQ36869908-BBF9BF2B-F288-4E89-823D-F97C22A71937Q36996171-849B2CC0-5D92-4DC8-961D-93716975F8C5Q37675217-0E8A51F7-1DD2-4722-AFC2-3CEED90B0985Q37730201-4ABE1128-260D-416C-A230-7275384A3561Q38434198-6BB3B59C-D192-4D53-921B-1A0F960A2673Q38560780-8888DA9F-98C2-4430-AC2F-7BF231A4D06DQ38619050-32A917AB-65AD-4DD0-A863-0F4F9F141FCFQ38637282-F39EBB2F-88A8-44BB-B313-AF840949F6EBQ38667215-4D84ECC2-A136-4EC8-A891-5055B65F77A7Q38685163-198B2610-8453-462A-BFDC-1E4D96897E3AQ38728960-9C017882-3DFA-457F-903A-F60D59745039Q38756189-9FC2DBF9-D5A5-4A20-B165-A36C72A2CC33Q39021324-A88EF0AA-2C55-4C43-B144-3B14959B400CQ39033205-40C12FF5-4A79-4169-B5E1-526427E8DECDQ39381359-B6884027-B07F-441F-BD13-C26E26096D5EQ40634360-B345A3C8-A4A3-4E90-A435-29548C44942CQ41918099-0FB25857-0597-4267-96B2-0FE1CA9DD3ACQ45886049-4F103D1F-9383-46B3-9287-DD7A0C2091B4Q46650820-1D19B81B-31C1-4266-AF06-220992F2F471Q48004039-B35A8CB4-01CD-4699-9942-7396E3A59454Q50076292-4EAA0B66-850D-4A4A-96FE-23E82B67E13DQ50349777-F324DEC9-5FC9-43AB-AA27-FAC1B661F80FQ51254236-8CF2E793-EB04-41D8-86FD-97F1202249C3Q52744998-3123C505-DFA8-4385-959C-EF97795363C6
P2860
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@ast
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@en
type
label
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@ast
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@en
altLabel
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
@en
prefLabel
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@ast
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@en
P2093
P2860
P50
P356
P1476
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
@en
P2093
Adel M Alwahadneh
Alessandro Moretta
Anne Marie Comeau
Arzu Ensari
Aydan İkincioğulları
Berna Savas
Cecilia Domínguez Conde
David B Goldstein
Emma Haapaniemi
Figen Doğu
P2860
P304
P356
10.1056/NEJMOA1413462
P407
P50
P577
2015-06-01T00:00:00Z